Zeus Launches Next-Generation Tubing for Bioresorbable Vascular Scaffolds

AI Accurately Interprets EEGs; Migraine Drugs Go Head-to-Head; A Nod to Oliver Sacks

An AI model interpreted routine clinical electroencephalograms (EEGs) as accurately as human experts. (JAMA Neurology) Women-specific health factors may influence Parkinson’s disease severity. (npj Parkinson’s

June 21, 2023

Penn state researchers receive $2 million NIH grant to develop new bioprinting technology

Developing technology to quickly and efficiently bioprint human tissues at scale is the goal of a new project led by Penn State researchers.

July 21, 2023

Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure | Psychedelic Invest

TORONTO, July 02, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused

July 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.